Loading clinical trials...
Loading clinical trials...
Financial Incentives to Improve Medication Adherence: a Pilot Study
Medication adherence is a challenge in all of medicine and is associated with multiple negative outcomes. Strategies to better measure and enhance adherence to medication are urgent and necessary to minimize unwanted health outcomes, hospitalizations, poorer quality of life and excessive costs for individuals, insurers and caregivers. Recently, behavioral economics-based approaches have emerged as a promising tool to address this unmet need, but its effectiveness in oral antipsychotic treatment remains to be assessed. For this project, investigators will use an app that offers financial incentives to increase compliance for patients with chronic diseases. Investigators intend to enroll 25 patients in a pilot project to assess feasibility of offering financial incentives to improve medication adherence in severe mental illness.
Age
18 - 80 years
Sex
ALL
Healthy Volunteers
No
The Zucker Hillside Hospital
Glen Oaks, New York, United States
Start Date
November 1, 2019
Primary Completion Date
May 30, 2020
Completion Date
March 2, 2022
Last Updated
September 21, 2023
25
ACTUAL participants
Wellth - Financial Incentives
OTHER
Lead Sponsor
Northwell Health
NCT07455929
NCT06740383
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions